| abstract |
Methods of treating bone cancer are disclosed. The methods comprise administering to a patient a therapeutically effective amount of a compound of formula (Ia) n nwherein R 1 , R 2 , R 3 , R 4 , and R 5 are described herein, wherein at least two of the five R 1 , R 2 , R 3 , R 4 , and R 5 substituents are always hydrogen, at least one of the five substituents is always nitro, and at least one substituent positioned adjacent to a nitro is always iodo, and pharmaceutically acceptable salts thereof. |